Right now, the bill as amended by the committee leaves schedule 1 of the Patent Act intact, and the schedule that was found in Bill C-393 now becomes schedule 2. There are two schedules. The first schedule, schedule 1, was the list of pharmaceutical products or drugs or--
On November 1st, 2010. See this statement in context.